Reported rates of diarrhea following oral penicillin therapy in pediatric clinical trials

Journal of Pediatric Pharmacology and Therapeutics

Volumn 20, Issue 2, 2015, Pages 90-104

  Kuehn, Jemima ^a,b   Ismael, Zareen ^c   Long, Paul F ^c   Barker, Charlotte I S ^d   Sharland, Mike ^a,d  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b University of London ^*  (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Amoxicillin; Amoxicillin clavulanate; Antibiotic; Antibiotic associated diarrhea; Oral penicillins; Penicillin V

Indexed keywords

EID: 85011253033     PISSN: 15516776     EISSN: 2331348X     Source Type: Journal    
DOI: 10.5863/1551-6776-20.2.90     Document Type: Review

References (57)

1. American Academy of Pediatrics and American Academy of Family Physicians. Clinical practice guideline on diagnosis and management of acute otitis media. Pediatrics. 2004;113(5):1450-1465.
2. Coker TR, Chan LS, Newberry SJ, et al. Diagnosis, microbial epidemiology and antibiotic treatment of acute otitis media in children: a systematic review. JAMA. 2010;304(19):2161-2169.
3. Bartlett JG. Antibiotic-associated diarrhea. N Engl J Med. 2002;346(5):334-339.
4. Coté GA, Buchman AL. Antibiotic-associated diarrhea. Expert Opin Drug Saf. 2006;5(3):361-372.
5. Mitchell DK, Van R, Mason EH, et al. Prospective study of toxigenic Clostridium difficile in children given amoxicillin/ clavanulate for otitis media. Pediatr Infect Dis J. 1996;15(6):514-519.
6. Hogenauer C, Hammer HF, Krejs GJ, et al. Mechanisms and management of antibiotic associated diarrhea. Clin Infect Dis. 1998;27(4):702-710.
7. Klein JO. Amoxicillin/clavulanate for infections in infants and children: past, present and future. Pediatr Infect Dis J. 2003;22(8):S139-S148.
8. Sandora TJ, Fung M, Flaherty K, et al. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J. 2011;30(7):580-584.
9. Zilberberg MD, Shorr AF, Kollef MH. Increase in Clostridium difficile-related hospitalisations among infants in the United States, 2000–2005. Pediatr Infect Dis J. 2008;27(12):1111-1113.10.
10. World Health Organization. Health topics: Diarrhoea. http://www.who.int/topics/diarrhea/en. Accessed December 14, 2014.
11. Division of Microbiology and Infectious Diseases (DMID). Pediatric toxicity tables November 2007 Draft. http://www.niaid.nih.gov/…/resources/DMIDClinRsrch/…/dmidpedtox.pdf. Accessed December 14, 2014.
12. National Institutes of Health. LiverTox: clinical and research information on drug-induced liver injury. Drug record for dicloxacillin. http://livertox.nlm.nih.gov/Dicloxacillin.htm. Accessed December 14, 2014.
13. Clegg HW, Ryan AG, Dallas SD, et al. Treatment of streptococcal pharyngitis with once-daily compared with twicedaily amoxicillin. Pediatr Infect Dis J. 2006;25(9):761-767.
14. Arguedas A, Emparanza P, Schwartz RH, et al. A randomized, multicenter, double blind, double dummy trial of single dose azithromycin versus high dose amoxicillin for treatment of uncomplicated acute otitis media. Pediatr Infect Dis J. 2005;24(2):153-161.
15. Damoiseaux RAMJ, Van Balen FAM, Hoes AW, et al. Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ. 2000;320(7231):350-354.
16. Cohen R, Levy C, Doit C, et al. Six day amoxicillin vs ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 1996;15(8):678-682.
17. Foshee WS, Qvarnberg Y. Comparative United States and European trials of loracarbef in the treatment of acute otitis media. Pediatr Infect Dis J. 1992;11(suppl 8):S12-S19.
18. McLinn SE, Goldberg F, Kramer R. Double-blind multicenter comparison of cyclacillin and amoxicillin for the treatment of acute otitis media. J Pediatr. 1982;101(4):617-621.
19. Tahtinen PA, Laine MK, Huovinen P, et al. A placebo-controlled trial of antimicrobial treatment for acute otitis media. N Engl J Med. 2011;364(2):116-126.
20. Poachanukoon O, Kitcharoensakkul M. Efficacy of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial. Clin Ther. 2008;30(10):1870-1879.
21. Block SL, Schmeir JK, Notario GF, et al. Efficacy, tolerability and parent reported outcomes for cefdinir vs high-dose amoxicillin/ clavulanate oral suspension for acute otitis media in young children. Curr Med Res Opin. 2006;22(9):1839-1847.
22. Lu Q, Chen HZ, Zhang LE, et al. A prospective multi-center randomised parallel study on efficacy and safety of cefaclor vs amoxicillin-clavulanate in children with acute bacterial infection of lower respiratory tract. Chin J Infect Chemother. 2006;6(2):77-81.
23. Sher L, Arguedas A, Husseman M, et al. Randomised, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children. Pediatr Infect Dis J. 2005;24(4):301-308.
24. Saez-Llorens X, Rodriguez A, Arguedas A, et al. Randomised, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/ clavulanate treatment of recurrent and nonresponsive otitis media in children. Pediatr Infect Dis J. 2005;24(4):293-300.
25. Block SL, Busman TA, Paris MM, et al. Comparison of five-day cefdinir treatment with ten-day low dose amoxicillin/clavulanate treatment for acute otitis media. Pediatr Infect Dis J. 2004;23(9):834-838.
26. Block SL, Arrieta A, Seibel M, et al. Singledose (30mg/kg) azithromycin compared with 10-day amoxicillin/clavulanate for the treatment of uncomplicated acute otitis media: a double-blind, placebo-controlled, randomised clinical trial. Curr Ther Res Clin Exp. 2003;64(suppl 1):A30-A42.
27. Arrieta A, Arguedas A, Fernandez P, et al. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. Antimicrob Agents Chemother. 2003;47(10):3179-3186.
28. Dunne MW, Latiolais T, Lewis B, et al. Randomised, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media. J Antimicrob Chemother. 2003;52(3):469-472.
29. Hedrick JA, Sher LD, Schwartz RH, et al. Cefprozil versus high-dose amoxicillin/ clavulanate in children with acute otitis media. Clin Ther. 2001;23(2):193-204.
30. Adler M, McDonald PJ, Trostmann U, et al. Cefdinir vs. amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children. Pediatr Infect Dis J. 2000;19(suppl 12):S166-S170.
31. Block SL, McCarty JM, Hedrick JA, et al. Comparative safety and efficacy of cefdinir vs. amoxicillin/clavulanate for treatment of suppurative acute otitis media in children. Pediatr Infect Dis J. 2000;19(suppl 12):S159-S165.
32. Pessey JJ, Gehanno P, Thoroddsen E, et al. Short course therapy with cefuroxime axetil for acute otitis media: results of a randomized multicenter comparison with amoxicillin/clavulanate. Pediatr Infect Dis J. 1999;18(10):854-859.
33. Cohen R, Navel M, Grunberg J, et al. One dose ceftriaxone vs. ten days of amoxicillin/ clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora. Pediatr Infect Dis J. 1999;18(5):403-409.
34. Bottenfield GW, Burch DJ, Hedrick JA, et al. Safety and tolerability of a new formulation (90mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae. Pediatr Infect Dis J. 1998;17(10):963-968.
35. Adam D. Modern cephalosporins as therapeutics for otitis media. Infect Dis Clin Pract (Baltim Md). 1998;7(suppl 2):S96-S98.
36. Harris JAS, Kolokathis A, Campbell M, et al. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J. 1998;17(10):865-871.
37. Behre U, Burow HM, Quinn P, et al. Efficacy of twice-daily dosing of amoxicillin/clavulanate in acute otitis media in children. Infection. 1997;25(3):163-166.
38. Hoberman A, Paradise JL, Burch DJ, et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatr Infect Dis J. 1997;16(5):463-470.
39. Gooch WM, Philips A, Rhoades R, et al. Comparison of the efficacy, safety and acceptability of cefixime and amoxicillin/ clavulanate in acute otitis media. Pediatr Infect Dis J. 1997;16(2):S21-S24.
40. Gooch WM, Blair E, Puopolo A, et al. Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media. Pediatr Infect Dis J. 1996;15(2):157-164.
41. McLinn SE, McCarty JM, Perrotta R, et al. Multicenter controlled trial comparing ceftibuten with amoxicillin/clavulanate in the empiric treatment of acute otitis media. Pediatr Infect Dis J. 1995;14(suppl 7):S108-S114.
42. McLinn SE, Moskal M, Goldfarb J, et al. Comparison of cefuroxime axetil and amoxicillin-clavulanate suspensions in treatment of acute otitis media with effusion in children. Antimicrob Agents Chemother. 1994;38(2):315-318.
43. McCarty JM, Phillips A, Wilsanen R. Comparative safety and efficacy of clarithromycin and amoxicillin/clavulanate in the treatment of acute otitis media in children. Pediatr Infect Dis J. 1993;12(suppl 12):S122-S127.
44. Schaad UB. Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children. J Antimicrob Chemother. 1993;31(suppl E):81-88.
45. Arguedas AG, Zaleska M, Stutman HR, et al. Comparative trial of cefprozil vs amoxicillin clavulanate potassium in the treatment of children with acute otitis media with effusion. Pediatr Infect Dis J. 1991;10(5):375-380.
46. Pichichero ME, McLinn SE, Gooch M, et al. Ceftibuten vs penicillin V in group A beta-hemolytic streptococcal pharyngitis. Pediatr Infect Dis J. 1995;14(7):S102-S107.
47. Block SL, Hedrick JA, Tyler RD. Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents. Pediatr Infect Dis J. 1992;11(11):919-925.
48. Alam S, Mushtaq M. Antibiotic associated diarrhea in children. Indian Pediatr. 2009;46(6):491-496.
49. Turck D, Bernet J-P, Marx J, et al. Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population. J Pediatr Gastroenterol Nutr. 2003;37(1):22-26.
50. De La Cochetiere M, Montassier E, Hardouin J, et al. Human intestinal microbiota gene risk factors for antibiotic-associated diarrhea: perspectives for prevention. Microb Biol. 2010;59(4):830-837.
51. Paediatric Formulary Committee. BNF for Children. London, England: BMJ Group; 2012.
52. Harrison CJ. Amoxicillin-clavulanate (Augmentin): an update. Rep Pediatr Infect Dis. 1992;2:26-27.
53. Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131(3):e964-e999.
54. Hoberman A, Paradise JL, Rockette HE, et al. Treatment of acute otitis media in children under 2 years of age. N Engl J Med. 2011;364(2):105-115.
55. Klein J. Editorial: is acute otitis media a treatable disease? N Engl J Med. 2011;364(2):168-169.
56. Johnston BC, Goldenberg JZ, Vandvik PO, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea (Review). Cochrane Database Syst Rev. 2013 May 31;5:CD006095.
57. Pichichero ME. Evaluating the need, timing and best choice of antibiotic therapy for acute otitis media and tonsillopharyngitis infections in children. Pediatr Infect Dis J. 2000;19(suppl 12):S131-S140.